Linda Wagner-Weiner to Child
This is a "connection" page, showing publications Linda Wagner-Weiner has written about Child.
Connection Strength
0.460
-
Intravenous Immunoglobulin in Pediatric Rheumatology: When to Use It and What Is the Evidence. Pediatr Ann. 2017 Jan 01; 46(1):e19-e24.
Score: 0.066
-
Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome. Pediatr Ann. 2015 Jun; 44(6):e142-7.
Score: 0.059
-
Pediatric rheumatology for the adult rheumatologist. J Clin Rheumatol. 2008 Apr; 14(2):109-19.
Score: 0.036
-
Adherence to medication by adolescents and young adults with childhood-onset systemic lupus erythematosus. Lupus. 2022 Oct; 31(12):1508-1515.
Score: 0.024
-
Laboratory evaluation of children with rheumatic disease. Pediatr Ann. 2002 Jun; 31(6):362-71.
Score: 0.024
-
Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2022 09; 74(9):1550-1558.
Score: 0.024
-
Epstein-Barr virus burden in adolescents with systemic lupus erythematosus. Pediatr Infect Dis J. 2001 Feb; 20(2):148-53.
Score: 0.022
-
Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis. J Rheumatol. 2021 07; 48(7):1073-1081.
Score: 0.022
-
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis Rheumatol. 2019 03; 71(3):451-459.
Score: 0.019
-
Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis. Pediatr Rheumatol Online J. 2018 Oct 22; 16(1):65.
Score: 0.019
-
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease. Arthritis Rheumatol. 2018 09; 70(9):1508-1518.
Score: 0.018
-
Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey. Pediatr Rheumatol Online J. 2017 Aug 07; 15(1):61.
Score: 0.017
-
Malignancy in Pediatric-onset Systemic Lupus Erythematosus. J Rheumatol. 2017 Oct; 44(10):1484-1486.
Score: 0.017
-
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. Arthritis Rheumatol. 2016 10; 68(10):2514-26.
Score: 0.016
-
A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America. Pediatr Rheumatol Online J. 2014; 12:24.
Score: 0.014
-
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012 Mar; 64(3):375-83.
Score: 0.012
-
Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum. 2012 Jan; 64(1):285-96.
Score: 0.012
-
Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus. 2010 Oct; 19(11):1315-25.
Score: 0.011
-
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009 May; 60(5):1496-507.
Score: 0.010
-
Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol. 2003 Feb; 30(2):394-400.
Score: 0.006
-
Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis. J Rheumatol. 2000 Dec; 27(12):2938-40.
Score: 0.005
-
Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis. Arthritis Rheum. 1993 Oct; 36(10):1370-4.
Score: 0.003
-
Intermittent intravenous cyclophosphamide therapy for lupus nephritis. J Pediatr. 1989 Jun; 114(6):1055-60.
Score: 0.002